FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of . | January |
, | 2018 |
CANON INC. | ||||
(Translation of registrants name into English) | ||||
30-2, Shimomaruko 3-Chome, Ohta-ku, Tokyo 146-8501, Japan | ||||
(Address of principal executive offices) |
[Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F |
X | Form 40-F |
[Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes |
No |
X |
[If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82-....................
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CANON INC. |
||
(Registrant) |
Date . |
January 30, 2018 | By /s/ Eiji Shimizu | ||||||
(Signature)* | ||||||||
Eiji Shimizu General Manager Consolidated Accounting Div. Canon Inc. |
*Print the name and title of the signing officer under his signature.
The following materials are included.
1. | RESULTS FOR THE FOURTH QUARTER AND THE FISCAL YEAR ENDED DECEMBER 31, 2017 |
RESULTS FOR THE FOURTH QUARTER
AND THE FISCAL YEAR ENDED DECEMBER 31, 2017
January 30, 2018
CONSOLIDATED RESULTS
(Millions of yen, thousands of U.S. dollars, except per share amounts) | ||||||||||||||||||||||||||||||||
|
Actual |
|
|
Projected |
| |||||||||||||||||||||||||||
Year ended December 31, 2017 |
Year ended December 31, 2016 |
Change(%) | Year ended December 31, 2017 |
Year ending December 31, 2018 |
Change(%) | |||||||||||||||||||||||||||
Net sales |
¥ | 4,080,015 | ¥ | 3,401,487 | + | 19.9 | $ | 36,106,327 | ¥ | 4,300,000 | + | 5.4 | ||||||||||||||||||||
Operating profit |
331,479 | 228,866 | + | 44.8 | 2,933,442 | 420,000 | + | 26.7 | ||||||||||||||||||||||||
Income before income taxes |
353,884 | 244,651 | + | 44.6 | 3,131,717 | 420,000 | + | 18.7 | ||||||||||||||||||||||||
Net income attributable to Canon Inc. |
¥ | 241,923 | ¥ | 150,650 | + | 60.6 | $ | 2,140,912 | ¥ | 280,000 | + | 15.7 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Net income attributable to Canon Inc. shareholders per share: |
|
|||||||||||||||||||||||||||||||
- Basic |
¥ | 222.88 | ¥ | 137.95 | + | 61.6 | $ | 1.97 | ¥ | 259.32 | + | 16.3 | ||||||||||||||||||||
- Diluted |
222.88 | 137.95 | + | 61.6 | 1.97 | - | - | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||
Actual | ||||||||||||||||||||||||||||||||
As of December 31, 2017 |
As of December 31, 2016 |
Change(%) | As of December 31, 2017 |
|||||||||||||||||||||||||||||
Total assets |
¥ | 5,198,291 | ¥ | 5,138,529 | + | 1.2 | $ | 46,002,575 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Canon Inc. shareholders equity |
¥ | 2,870,630 | ¥ | 2,783,129 | + | 3.1 | $ | 25,403,805 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
Notes: | 1. | Canons consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles. | ||
2. | U.S. dollar amounts are translated from yen at the rate of JPY 113= U.S.$1, the approximate exchange rate on the Tokyo Foreign Exchange Market as of December 29, 2017, solely for the convenience of the reader. |
Canon Inc. |
30-2, Shimomaruko 3-chome, Ohta-ku, | |
Headquarter office |
Tokyo 146-8501, Japan | |
Phone: +81-3-3758-2111 |
- 1 -
I. Operating Results and Financial Conditions
2017 in Review
Looking back at the global economy in 2017, the U.S. economy continued to grow steadily as employment conditions and corporate earnings improved. In Europe, the economy remained stable as unemployment rates decreased and capital investment increased due to strong exports. The Chinese economy rallied due to public investments while the economies of emerging countries realized moderate recovery as the economies of Russia and Brazil bottomed out owing to the rising price of natural resources. In Japan, corporate earnings improved and consumer spending showed signs of recovery. As a result, the global economy overall continued to recover more robustly than was expected at the beginning of the year.
As for the markets in which Canon operates amid these conditions, demand for office multifunction devices (MFDs) and laser printers remained at around the same level as the previous year. While demand for cameras shrank moderately, demand for inkjet printers increased from the previous year with the economies recovering in emerging countries. Additionally, there was solid demand for medical equipment, mainly outside of Japan. Within the Industry and Others sector, demand for flat panel display (FPD) lithography equipment and manufacturing equipment for organic LED (OLED) panels enjoyed strong growth and the demand for network camera also enjoyed solid growth.
The average value of the yen during the year was ¥112.13 against the U.S. dollar, a year-on-year depreciation of approximately ¥4, and ¥126.69 against the euro, a year-on-year depreciation of approximately ¥6.
During 2017, unit sales of office MFDs increased compared with the previous year due to the expanded sales of color models. Additionally, unit sales of laser printers increased compared with the previous year, supported by the steady sales of newly launched models, as demand recovered in emerging countries. While unit sales of interchangeable-lens digital cameras decreased compared with the previous year, unit sales of digital compact cameras remained at around the same level amid the shrinking market, owing to increased sales of high-value-added models. Looking at inkjet printers, unit sales increased compared with the previous year, thanks to such factors as strong sales of newly launched home-use models and refillable ink tank models for emerging countries. Additionally, sales of semiconductor lithography equipment, FPD lithography equipment, and manufacturing equipment for OLED panels exceeded those of the previous year, thanks to favorable market conditions, and sales of network cameras increased steadily in response to the growing market. Under these conditions, along with the impact of acquiring Toshiba Medical Systems Corporation (TMSC) (Canon Medical Systems Corporation as of January 4th, 2018), net sales for the year increased by 19.9% year on year to ¥4,080.0 billion. Although the gross profit ratio decreased by 0.4 points to 48.8% due to the effect of the product mix, gross profit increased by 19.0% year on year to ¥1,992.7 billion, thanks to such factors as the increase in sales and continuous cost reduction efforts. Operating expenses increased by 15.0% year on year, mainly due to impairment loss on goodwill of commercial printing business in Office Business Unit and the impact of acquiring TMSC. As a result, operating profit increased by 44.8% to ¥331.5 billion. Adjusted operating profit, which excludes impairment losses on goodwill from operating profit as they are considered nonrecurring charges, increased by 59.7% to ¥365.4 billion. Other income (deductions) increased by ¥6.6 billion mainly due to gain on securities contributed to retirement benefit trust and foreign currency exchange losses while income before income taxes increased by 44.6% year on year to ¥353.9 billion and net income attributable to Canon Inc. increased by 60.6% to ¥241.9 billion.
Basic net income attributable to Canon Inc. shareholders per share for the year was ¥222.88, a year-on-year increase of ¥84.93.
- 2 -
Results by Segment
Looking at Canons full-year performance by business unit, beginning with the Office Business Unit, unit sales of office MFDs increased from the previous year and achieved higher growth than the market average, supported by steady sales of next-generation color models designed to strengthen the product lineup such as the newly launched color A3 (12x18) imageRUNNER ADVANCE C3500 series for small- and medium-size offices. Among high-speed continuous-feed printers, unit sales of the Océ-produced VarioPrint i300, a high-speed sheet-fed color inkjet press that offers superior low-running-cost performance, increased. As for laser printers, sales of both hardware and consumables increased from the previous year, supported by steady sales of new models that achieve low power consumption and compact body designs. These factors resulted in total sales for the business unit of ¥1,865.9 billion, a year-on-year increase of 3.2%, while operating profit totaled ¥180.6 billion, a year-on-year increase of 6.6%. Adjusted operating profit, which excludes impairment losses on goodwill from operating profit, increased by 26.6% to ¥214.6 billion.
Within the Imaging System Business Unit, while the pace of decline in demand for interchangeable-lens digital cameras is gradually decelerating, the sales of the advanced-amateur-models including the EOS 6D Mark IIenjoyed solid demand, allowing Canon to maintain the top share, mainly in the United States, Europe, and Japan. As for compact-system cameras, the advanced-amateur-model EOS M6 and the entry-level EOS M100 enjoyed strong demand. As for digital compact cameras, amid the shrinking market, unit sales remained at the same level as the previous year, supported by the increased sales of such high-value-added models as the newly launched G9 X Mark IIpart of the high-image-quality PowerShot G-series lineup. As for inkjet printers, the newly designed home-use TS-series, refillable ink tank models targeting emerging countries and the imagePROGRAF PRO series of large format inkjet printer targeting the professional photo and graphic art markets enjoyed strong demand, resulting in unit sales increasing from the previous year. As a result, sales for the business unit increased by 3.7% year on year to ¥1,136.2 billion, while operating profit totaled ¥175.9 billion, a year-on-year increase of 21.8%.
Within the Medical System Business Unit, TMSCs computed tomography (CT) products increased the sales and maintained the top share in the Japanese market thanks to the solid sales of the newly launched Aquilion Precision CT scanner, which delivers the industrys highest level of high-resolution imaging. As for diagnostic ultrasound systems, sale of the Aplio i-series, which delivers proprietary high-resolution imaging technology, remained firm. As a result, sales for the business unit totaled ¥436.2 billion, while operating profit totaled ¥22.5 billion.
In the Industry and Others Business Unit, unit sales of semiconductor lithography equipment increased from the previous year as a result of increasing demand for memory devices used in data centers. Additionally, sales of FPD lithography equipment and manufacturing equipment for OLED panels increased significantly in response to continued growing demand for high-definition OLED displays used in mobile devices. As for network cameras, amid increasing market demand, Axis enjoyed solid sales, resulting in a considerable sales increase compared with the previous year. Consequently, sales for the business unit increased by 25.2% year on year to ¥731.7 billion, while operating profit grew by ¥49.3 billion from the previous year to ¥56.8 billion.
Cash Flow
During 2017, cash flow from operating activities totaled ¥590.6 billion, an increase of ¥90.3 billion compared with the previous year, mainly owing to improvements in profitability. Cash flow from investing activities decreased by ¥672.1 billion year on year to ¥165.0 billion due to the payment made in the previous year for the right to acquire all of the shares of TMSC. Accordingly, free cash flow totaled ¥425.5 billion, an increase of ¥762.4 billion compared with the corresponding year-ago period.
Cash flow from financing activities recorded an outlay of ¥340.5 billion, mainly owing to the dividend payout, the repurchasing of treasury stock and the repayment of long-term debt.
Owing to these factors, as well as the impact of foreign currency translation adjustments, cash and cash equivalents increased by ¥91.6 billion to ¥721.8 billion from the end of the previous year.
- 3 -
Outlook
As for the outlook for 2018, the U.S. economy is expected to recover stronger as corporate earnings and capital investments steadily improve thanks to tax reform. The European economy is expected to recover slowly due to increasing uncertainty surrounding the U.K.s decision to leave the EU, although consumer spending is expected to remain stable due to solid employment conditions. Looking at China, the economy is expected to stabilize through public investments and solid consumer spending. Emerging economies, including Southeast Asia, are expected to continue to grow due to strong exports. With regard to the Japanese economy, the outlook indicates a trend of gradual recovery supported by improved employment conditions and consumer spending. Overall, the global economy is expected to continue achieving moderate growth, despite such concerns as increasing geopolitical risks.
In the businesses in which Canon is involved, for office MFDs, demand for color models is expected to grow moderately and make up for the contraction of the market for monochrome models, leading to the same level of demand overall compared with the previous year. Looking at the laser printer market, although the demand in developed countries is expected to decrease, demand in emerging countries continues to recover, resulting in overall demand remaining at the same level as the previous year. For interchangeable-lens digital cameras, demand is expected to decrease moderately. Projections for digital compact cameras indicate continued market contraction, centered mainly on low-priced models, despite solid demand for high-value-added models. With regard to inkjet printers, demand is expected to continue to exceed that of the previous year. As for the medical equipment market, demand is expected to remain firm in response to replacement demand for medical equipment in developed countries, increasing medical needs associated with population growth in emerging countries and changes in the prevalence of diseases. Looking at industrial equipment, within the semiconductor lithography equipment segment, the market is expected to enjoy healthy growth due to the increase in demand for memory devices used in data centers and mobile devices. The outlook for FPD lithography equipment and OLED panel manufacturing equipment points to continued active capital investment by panel manufacturers, which is expected to increase demand. The network camera market is also expected to grow in response to the increasing use of network cameras for diverse applications in such areas as marketing support in addition to disaster monitoring and crime prevention applications.
With regard to currency exchange rates for the year, on which Canons performance outlook is based, Canon anticipates exchange rates of ¥110 to the U.S. dollar and ¥130 to the euro, representing appreciation of approximately ¥2 against the U.S. dollar and depreciation of approximately ¥3 against the euro compared with the annual average rates of the previous year.
Upon taking into consideration the current economic forecast, Canon projects full-year consolidated net sales in 2018 of ¥4,300.0 billion, a year-on-year increase of 5.4%; operating profit of ¥420.0 billion, a year-on-year increase of 26.7%; income before income taxes of ¥420.0 billion, a year-on-year increase of 18.7%; and net income attributable to Canon Inc. of ¥280.0 billion, a year-on-year increase of 15.7%.
- 4 -
This document contains forward-looking statements with respect to future results, performance and achievements that are subject to risk and uncertainties and reflect managements views and assumptions formed by available information. All statements other than statements of historical fact are statements that could be considered forward-looking statements. When used in this document, words such as anticipate, believe, estimate, expect, intend, may, plan, project or should and similar expressions, as they relate to Canon, are intended to identify forward-looking statements. Many factors could cause the actual results, performance or achievements of Canon to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, changes in general economic and business conditions, changes in currency exchange rates and interest rates, introduction of competing products by other companies, lack of acceptance of new products or services by Canons targeted customers, inability to meet efficiency and cost reduction objectives, changes in business strategy and various other factors, both referenced and not referenced in this document. A detailed description of these and other risk factors is included in Canons annual report on Form 20-F, which is on file with the United States Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein. Canon does not intend or assume any obligation to update these forward-looking statements.
II. Basic Concept Regarding the Selection of Accounting Standards
Canon is listed on the New York Stock Exchange and, since registering its American Depositary Receipts on the OTC (over-the-counter) market in 1969, has prepared its consolidated financial statements in accordance with U.S. generally accepted accounting principles (GAAP) over the long term.
Canon has continued to adopt U.S. GAAP in order to maintain the continuity of financial statements from the past and to maintain international comparability.
- 5 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
III. Financial Statements
1. CONSOLIDATED BALANCE SHEETS
Millions of yen | ||||||||||||
As of December 31, 2017 |
As of December 31, 2016 |
Change | ||||||||||
ASSETS |
||||||||||||
Current assets: |
||||||||||||
Cash and cash equivalents |
721,814 | 630,193 | 91,621 | |||||||||
Short-term investments |
1,965 | 3,206 | (1,241) | |||||||||
Trade receivables, net |
650,872 | 641,458 | 9,414 | |||||||||
Inventories |
570,033 | 560,736 | 9,297 | |||||||||
Prepaid expenses and other current assets |
287,965 | 264,155 | 23,810 | |||||||||
|
|
|
|
|
|
|||||||
Total current assets |
2,232,649 | 2,099,748 | 132,901 | |||||||||
Noncurrent receivables |
35,444 | 29,297 | 6,147 | |||||||||
Investments |
48,320 | 73,680 | (25,360) | |||||||||
Property, plant and equipment, net |
1,126,620 | 1,194,976 | (68,356) | |||||||||
Intangible assets, net |
420,972 | 446,268 | (25,296) | |||||||||
Goodwill |
936,722 | 936,424 | 298 | |||||||||
Other assets |
397,564 | 358,136 | 39,428 | |||||||||
|
|
|
|
|
|
|||||||
Total assets |
5,198,291 | 5,138,529 | 59,762 | |||||||||
|
|
|
|
|
|
|||||||
LIABILITIES AND EQUITY |
||||||||||||
Current liabilities: |
||||||||||||
Short-term loans and current portion of long-term debt |
39,328 | 1,850 | 37,478 | |||||||||
Trade payables |
380,654 | 372,269 | 8,385 | |||||||||
Accrued income taxes |
77,501 | 30,514 | 46,987 | |||||||||
Accrued expenses |
330,188 | 304,901 | 25,287 | |||||||||
Other current liabilities |
281,809 | 273,835 | 7,974 | |||||||||
|
|
|
|
|
|
|||||||
Total current liabilities |
1,109,480 | 983,369 | 126,111 | |||||||||
Long-term debt, excluding current installments |
493,238 | 611,289 | (118,051) | |||||||||
Accrued pension and severance cost |
365,582 | 407,200 | (41,618) | |||||||||
Other noncurrent liabilities |
133,816 | 142,049 | (8,233) | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities |
2,102,116 | 2,143,907 | (41,791) | |||||||||
|
|
|
|
|
|
|||||||
Equity: |
||||||||||||
Canon Inc. shareholders equity: |
||||||||||||
Common stock |
174,762 | 174,762 | - | |||||||||
Additional paid-in capital |
401,386 | 401,385 | 1 | |||||||||
Legal reserve |
66,879 | 66,558 | 321 | |||||||||
Retained earnings |
3,429,312 | 3,350,728 | 78,584 | |||||||||
Accumulated other comprehensive income (loss) |
(143,228) | (199,881) | 56,653 | |||||||||
Treasury stock, at cost |
(1,058,481) | (1,010,423) | (48,058) | |||||||||
|
|
|
|
|
|
|||||||
Total Canon Inc. shareholders equity |
2,870,630 | 2,783,129 | 87,501 | |||||||||
Noncontrolling interests |
225,545 | 211,493 | 14,052 | |||||||||
|
|
|
|
|
|
|||||||
Total equity |
3,096,175 | 2,994,622 | 101,553 | |||||||||
|
|
|
|
|
|
|||||||
Total liabilities and equity |
5,198,291 | 5,138,529 | 59,762 | |||||||||
|
|
|
|
|
|
|||||||
Millions of yen |
||||||||||||
As of December 31, 2017 |
As of December 31, 2016 |
|||||||||||
Notes: |
||||||||||||
1. Allowance for doubtful receivables |
13,378 | 11,075 | ||||||||||
2. Accumulated depreciation |
2,638,055 | 2,578,342 | ||||||||||
3. Accumulated other comprehensive income (loss): |
||||||||||||
Foreign currency translation adjustments |
30,208 | (13,960) | ||||||||||
Net unrealized gains and losses on securities |
5,484 | 15,251 | ||||||||||
Net gains and losses on derivative instruments |
(180) | (2,742) | ||||||||||
Pension liability adjustments |
(178,740) | (198,430) |
- 6 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
2. CONSOLIDATED STATEMENTS OF INCOME AND
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Consolidated statements of income |
||||||||||||||||
Results for the fourth quarter | Millions of yen | |||||||||||||||
Three months ended December 31, 2017 |
Three months ended December 31, 2016 |
Change(%)
|
||||||||||||||
Net sales |
1,120,291 | 965,173 | + | 16.1 | ||||||||||||
Cost of sales |
573,730 | 505,066 | ||||||||||||||
|
|
|
|
|||||||||||||
Gross profit |
546,561 | 460,107 | + | 18.8 | ||||||||||||
Operating expenses: |
||||||||||||||||
Selling, general and administrative expenses |
346,804 | 305,987 | ||||||||||||||
Research and development expenses |
86,809 | 73,952 | ||||||||||||||
Impairment losses on goodwill |
33,912 | - | ||||||||||||||
|
|
|
|
|||||||||||||
467,525 | 379,939 | |||||||||||||||
|
|
|
|
|||||||||||||
Operating profit |
79,036 | 80,168 | - | 1.4 | ||||||||||||
Other income (deductions): |
||||||||||||||||
Interest and dividend income |
1,478 | 1,178 | ||||||||||||||
Interest expense |
(236 | ) | (219 | ) | ||||||||||||
Other, net |
8,239 | (8,492 | ) | |||||||||||||
|
|
|
|
|||||||||||||
9,481 | (7,533 | ) | ||||||||||||||
|
|
|
|
|||||||||||||
Income before income taxes |
88,517 | 72,635 | + | 21.9 | ||||||||||||
Income taxes |
28,776 | 22,751 | ||||||||||||||
|
|
|
|
|||||||||||||
Consolidated net income |
59,741 | 49,884 | ||||||||||||||
Less: Net income attributable to noncontrolling interests |
5,138 | 5,054 | ||||||||||||||
|
|
|
|
|||||||||||||
Net income attributable to Canon Inc. |
54,603 | 44,830 | + | 21.8 | ||||||||||||
|
|
|
|
|||||||||||||
Note |
||||||||||||||||
Canon includes Adjusted operating profit, which is a non-U.S. GAAP measure, in its disclosure. We believe this measure helps investors better understand Canons recurring business performance. A reconciliation from Operating profit to Adjusted operating profit is set forth on the following table. |
| |||||||||||||||
Reconciliation from Operating profit to Adjusted operating profit |
| |||||||||||||||
Millions of yen | ||||||||||||||||
Three months ended December 31, 2017 |
Three months ended December 31, 2016 |
|||||||||||||||
Operating profit |
79,036 | 80,168 | ||||||||||||||
Impairment losses on goodwill |
33,912 | - | ||||||||||||||
|
|
|
|
|||||||||||||
Adjusted operating profit |
112,948 | 80,168 | ||||||||||||||
|
|
|
|
- 7 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
Consolidated statements of income | ||||||||
Results for the fiscal year |
Millions of yen | |||||||
Year ended December 31, 2017 |
Year ended |
Change(%)
| ||||||
Net sales |
4,080,015 | 3,401,487 | + 19.9 | |||||
Cost of sales |
2,087,324 | 1,727,654 | ||||||
Gross profit |
1,992,691 | 1,673,833 | + 19.0 | |||||
|
|
|
||||||
Operating expenses: |
||||||||
Selling, general and administrative expenses |
1,297,247 | 1,142,591 | ||||||
Research and development expenses |
330,053 | 302,376 | ||||||
Impairment losses on goodwill |
33,912 | - | ||||||
|
|
|
||||||
1,661,212 | 1,444,967 | |||||||
|
|
|
||||||
Operating profit |
331,479 | 228,866 | + 44.8 | |||||
Other income (deductions): |
||||||||
Interest and dividend income |
6,012 | 4,762 | ||||||
Interest expense |
(818) | (1,061) | ||||||
Other, net |
17,211 | 12,084 | ||||||
|
|
|
||||||
22,405 | 15,785 | |||||||
|
|
|
||||||
Income before income taxes |
353,884 | 244,651 | + 44.6 | |||||
Income taxes |
98,024 | 82,681 | ||||||
|
|
|
||||||
Consolidated net income |
255,860 | 161,970 | ||||||
Less: Net income attributable to noncontrolling interests |
13,937 | 11,320 | ||||||
|
|
|
||||||
Net income attributable to Canon Inc. |
241,923 | 150,650 | + 60.6 | |||||
|
|
|
||||||
Note Canon includes Adjusted operating profit, which is a non-U.S. GAAP measure, in its disclosure. We believe this measure helps investors better understand Canons recurring business performance. A reconciliation from Operating profit to Adjusted operating profit is set forth on the following table. | ||||||||
Reconciliation from Operating profit to Adjusted operating profit | ||||||||
Millions of yen | ||||||||
Year ended December 31, 2017 |
Year ended |
|||||||
Operating profit |
331,479 | 228,866 | ||||||
Impairment losses on goodwill |
33,912 | - | ||||||
|
|
|
||||||
Adjusted operating profit |
365,391 | 228,866 | ||||||
|
|
|
- 8 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
Consolidated statements of comprehensive income | ||||||||
Results for the fourth quarter |
Millions of yen | |||||||
Three months ended December 31, 2017 |
Three months ended |
Change(%)
| ||||||
Consolidated net income |
59,741 | 49,884 | + 19.8 | |||||
Other comprehensive income (loss), net of tax: |
||||||||
Foreign currency translation adjustments |
9,001 | 189,007 | ||||||
Net unrealized gains and losses on securities |
(4,859) | 5,184 | ||||||
Net gains and losses on derivative instruments |
909 | (4,514) | ||||||
Pension liability adjustments |
20,975 | (72,975) | ||||||
|
|
|
||||||
26,026 | 116,702 | |||||||
|
|
|
||||||
Comprehensive income (loss) |
85,767 | 166,586 | - 48.5 | |||||
Less: Comprehensive income attributable to noncontrolling interests |
7,731 | 5,584 | ||||||
|
|
|
||||||
Comprehensive income (loss) attributable to Canon Inc. |
78,036 | 161,002 | - 51.5 | |||||
|
|
|
||||||
Results for the fiscal year |
Millions of yen | |||||||
Year ended December 31, 2017 |
Year ended |
Change(%)
| ||||||
Consolidated net income |
255,860 | 161,970 | + 58.0 | |||||
Other comprehensive income (loss), net of tax: |
||||||||
Foreign currency translation adjustments |
47,090 | (107,666) | ||||||
Net unrealized gains and losses on securities |
(9,362) | 997 | ||||||
Net gains and losses on derivative instruments |
2,588 | (2,948) | ||||||
Pension liability adjustments |
21,207 | (70,355) | ||||||
|
|
|
||||||
61,523 | (179,972) | |||||||
|
|
|
||||||
Comprehensive income (loss) |
317,383 | (18,002) | - | |||||
Less: Comprehensive income attributable to noncontrolling interests |
18,807 | 1,745 | ||||||
|
|
|
||||||
Comprehensive income (loss) attributable to Canon Inc. |
298,576 | (19,747) | - | |||||
|
|
|
- 9 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
3. DETAILS OF SALES
Results for the fourth quarter |
Millions of yen | |||||||||||||||
Sales by business unit | Three months ended December 31, 2017 |
Three months ended December 31, 2016 |
Change(%)
|
|||||||||||||
Office |
493,199 | 485,850 | + | 1.5 | ||||||||||||
Imaging System |
340,920 | 324,742 | + | 5.0 | ||||||||||||
Medical System |
103,682 | - | - | |||||||||||||
Industry and Others |
205,284 | 175,634 | + | 16.9 | ||||||||||||
Eliminations |
(22,794) | (21,053) | - | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
1,120,291 | 965,173 | + | 16.1 | ||||||||||||
|
|
|
|
|
|
|||||||||||
Millions of yen | ||||||||||||||||
Sales by region | Three months ended December 31, 2017 |
Three months ended December 31, 2016 |
Change(%) | |||||||||||||
Japan |
242,692 | 205,096 | + | 18.3 | ||||||||||||
Overseas: |
||||||||||||||||
Americas |
303,277 | 267,467 | + | 13.4 | ||||||||||||
Europe |
289,104 | 262,324 | + | 10.2 | ||||||||||||
Asia and Oceania |
285,218 | 230,286 | + | 23.9 | ||||||||||||
|
|
|
|
|
|
|||||||||||
877,599 | 760,077 | + | 15.5 | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
1,120,291 | 965,173 | + | 16.1 | ||||||||||||
|
|
|
|
|
|
|||||||||||
*Canon newly established Medical System Business Unit effective at the beginning of the second quarter of 2017, and certain businesses included in Industry and Others Business Unit have been reclassified. Net sales for the three months ended December 31, 2016 were not restated since they were not material. |
| |||||||||||||||
Results for the fiscal year | Millions of yen | |||||||||||||||
Sales by business unit | Year ended December 31, 2017 |
Year ended December 31, 2016 |
Change(%) | |||||||||||||
Office |
1,865,928 | 1,807,819 | + | 3.2 | ||||||||||||
Imaging System |
1,136,188 | 1,095,289 | + | 3.7 | ||||||||||||
Medical System |
436,187 | - | - | |||||||||||||
Industry and Others |
731,704 | 584,660 | + | 25.2 | ||||||||||||
Eliminations |
(89,992) | (86,281) | | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
4,080,015 | 3,401,487 | + | 19.9 | ||||||||||||
|
|
|
|
|
|
|||||||||||
Millions of yen | ||||||||||||||||
Sales by region | Year ended December 31, 2017 |
Year ended December 31, 2016 |
Change(%) | |||||||||||||
Japan |
884,828 | 706,979 | + | 25.2 | ||||||||||||
Overseas: |
||||||||||||||||
Americas |
1,107,515 | 963,544 | + | 14.9 | ||||||||||||
Europe |
1,028,415 | 913,523 | + | 12.6 | ||||||||||||
Asia and Oceania |
1,059,257 | 817,441 | + | 29.6 | ||||||||||||
|
|
|
|
|
|
|||||||||||
3,195,187 | 2,694,508 | + | 18.6 | |||||||||||||
|
|
|
|
|
|
|||||||||||
Total |
4,080,015 | 3,401,487 | + | 19.9 | ||||||||||||
|
|
|
|
|
|
|||||||||||
*Canon newly established Medical System Business Unit effective at the beginning of the second quarter of 2017, and certain businesses included in Industry and Others Business Unit have been reclassified. Net sales for the year ended December 31, 2016 were not restated since they were not material. |
|
Notes: | 1. | The primary products included in each of the segments are as follows: Office Business Unit : Office multifunction devices (MFDs) / Laser multifunction printers (MFPs) / Laser printers / Digital production printing systems / High speed continuous feed printers / Wide-format printers / Document solutions Imaging System Business Unit : Interchangeable lens digital cameras / Digital compact cameras / Digital camcorders / Digital cinema cameras / Interchangeable lenses / Compact photo printers / Inkjet printers / Large format inkjet printers / Commercial photo printers / Image scanners / Multimedia projectors / Broadcast equipment / Calculators Medical System Business Unit : Digital radiography systems / Diagnostic x-ray systems / Computed tomography / Magnetic resonance imaging / Diagnostic ultrasound systems / Clinical chemistry analyzers / Ophthalmic equipment Industry and Others Business Unit : Semiconductor lithography equipment / FPD (Flat panel display) lithography equipment / Vacuum thin-film deposition equipment / Organic LED (OLED) panel manufacturing equipment / Die bonders / Micromotors / Network cameras / Handy terminals / Document scanners | ||
2. | The principal countries and regions included in each regional category are as follows: Americas: United States of America, Canada, Latin America Europe: United Kingdom, Germany, France, Netherlands, European countries, Middle East and Africa Asia and Oceania: China, Asian countries, Australia |
- 10 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
4. CONSOLIDATED STATEMENTS OF EQUITY
Millions of yen
Common Stock |
Additional paid-in capital |
Legal reserve |
Retained earnings |
Accumulated other income (loss) |
Treasury stock |
Total Canon Inc. shareholders equity |
Noncontrolling interests |
Total equity | ||||||||||||||||||||||||||
Balance at December 31, 2015 |
174,762 | 401,358 | 65,289 | 3,365,158 | (29,742 | ) | (1,010,410 | ) | 2,966,415 | 218,048 | 3,184,463 | |||||||||||||||||||||||
Equity transactions with noncontrolling interests and other |
27 | 258 | 285 | (5,270 | ) | (4,985) | ||||||||||||||||||||||||||||
Dividends to Canon Inc. shareholders |
(163,810 | ) | (163,810 | ) | (163,810) | |||||||||||||||||||||||||||||
Dividends to noncontrolling interests |
(4,077 | ) | (4,077) | |||||||||||||||||||||||||||||||
Acquisition of subsidiaries |
1,047 | 1,047 | ||||||||||||||||||||||||||||||||
Transfers to legal reserve |
1,269 | (1,269 | ) | - | - | |||||||||||||||||||||||||||||
Comprehensive income: |
||||||||||||||||||||||||||||||||||
Net income |
150,650 | 150,650 | 11,320 | 161,970 | ||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax: |
||||||||||||||||||||||||||||||||||
Foreign currency translation adjustments |
(101,257 | ) | (101,257 | ) | (6,409 | ) | (107,666) | |||||||||||||||||||||||||||
Net unrealized gains and losses on securities |
1,196 | 1,196 | (199 | ) | 997 | |||||||||||||||||||||||||||||
Net gains and losses on derivative instruments |
(2,924 | ) | (2,924 | ) | (24 | ) | (2,948) | |||||||||||||||||||||||||||
Pension liability adjustments |
(67,412 | ) | (67,412 | ) | (2,943 | ) | (70,355) | |||||||||||||||||||||||||||
Total comprehensive income (loss) |
(19,747 | ) | 1,745 | (18,002) | ||||||||||||||||||||||||||||||
Repurchases and reissuance of treasury stock |
(1 | ) | (13 | ) | (14 | ) | (14) | |||||||||||||||||||||||||||
Balance at December 31, 2016 |
174,762 | 401,385 | 66,558 | 3,350,728 | (199,881 | ) | (1,010,423) | 2,783,129 | 211,493 | 2,994,622 | ||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||
Equity transactions with noncontrolling interests and other |
1 | 1 | (1 | ) | - | |||||||||||||||||||||||||||||
Dividends to Canon Inc. shareholders |
(162,887 | ) | (162,887 | ) | (162,887) | |||||||||||||||||||||||||||||
Dividends to noncontrolling interests |
(4,814 | ) | (4,814) | |||||||||||||||||||||||||||||||
Acquisition of subsidiaries |
60 | 60 | ||||||||||||||||||||||||||||||||
Transfers to legal reserve |
321 | (321 | ) | - | - | |||||||||||||||||||||||||||||
Comprehensive income: |
||||||||||||||||||||||||||||||||||
Net income |
241,923 | 241,923 | 13,937 | 255,860 | ||||||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax: |
||||||||||||||||||||||||||||||||||
Foreign currency translation adjustments |
44,168 | 44,168 | 2,922 | 47,090 | ||||||||||||||||||||||||||||||
Net unrealized gains and losses on securities |
(9,767 | ) | (9,767 | ) | 405 | (9,362) | ||||||||||||||||||||||||||||
Net gains and losses on derivative instruments |
2,562 | 2,562 | 26 | 2,588 | ||||||||||||||||||||||||||||||
Pension liability adjustments |
19,690 | 19,690 | 1,517 | 21,207 | ||||||||||||||||||||||||||||||
Total comprehensive income (loss) |
298,576 | 18,807 | 317,383 | |||||||||||||||||||||||||||||||
Repurchases of treasury stock |
(50,036 | ) | (50,036 | ) | (50,036) | |||||||||||||||||||||||||||||
Reissuance of treasury stock |
(131 | ) | 1,978 | 1,847 | 1,847 | |||||||||||||||||||||||||||||
Balance at December 31, 2017 |
174,762 | 401,386 | 66,879 | 3,429,312 | (143,228 | ) | (1,058,481 | ) | 2,870,630 | 225,545 | 3,096,175 | |||||||||||||||||||||||
|
- 11 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
5. CONSOLIDATED STATEMENTS OF CASH FLOWS
Millions of yen | ||||||||
Year ended December 31, 2017 |
Year ended December 31, 2016 |
|||||||
Cash flows from operating activities: |
||||||||
Consolidated net income |
255,860 | 161,970 | ||||||
Adjustments to reconcile consolidated net income to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
261,881 | 250,096 | ||||||
Loss on disposal of fixed assets |
6,935 | 5,203 | ||||||
Impairment losses on goodwill |
33,912 | - | ||||||
Gain on securities contributed to retirement benefit trust |
(17,836) | - | ||||||
Deferred income taxes |
(17,603) | 7,188 | ||||||
(Increase) decrease in trade receivables |
3,563 | (4,155) | ||||||
Decrease in inventories |
2,967 | 6,156 | ||||||
Increase in trade payables |
4,951 | 56,844 | ||||||
Increase (decrease) in accrued income taxes |
46,296 | (16,456) | ||||||
Increase (decrease) in accrued expenses |
18,503 | (5,256) | ||||||
Increase in accrued (prepaid) pension and severance cost |
522 | 5,489 | ||||||
Other, net |
(9,394) | 33,204 | ||||||
|
|
|
|
|||||
Net cash provided by operating activities |
590,557 | 500,283 | ||||||
Cash flows from investing activities: |
||||||||
Purchases of fixed assets |
(189,484) | (206,971) | ||||||
Proceeds from sale of fixed assets |
26,444 | 6,177 | ||||||
Purchases of available-for-sale securities |
(2,220) | (84) | ||||||
Proceeds from sale and maturity of available-for-sale securities |
970 | 1,181 | ||||||
Decrease in time deposits, net |
3,373 | 15,414 | ||||||
Acquisitions of businesses, net of cash acquired |
(6,557) | (649,570) | ||||||
Purchases of other investments |
(928) | (4,460) | ||||||
Other, net |
3,392 | 1,188 | ||||||
|
|
|
|
|||||
Net cash used in investing activities |
(165,010) | (837,125) | ||||||
Cash flows from financing activities: |
||||||||
Proceeds from issuance of long-term debt |
1,570 | 610,552 | ||||||
Repayments of long-term debt |
(126,578) | (856) | ||||||
Increase (decrease) in short-term loans, net |
5,628 | (80,580) | ||||||
Purchases of noncontrolling interests |
- | (4,993) | ||||||
Dividends paid |
(162,887) | (163,810) | ||||||
Repurchases and reissuance of treasury stock |
(50,034) | (14) | ||||||
Other, net |
(8,163) | (4,607) | ||||||
|
|
|
|
|||||
Net cash provided by (used in) financing activities |
(340,464) | 355,692 | ||||||
Effect of exchange rate changes on cash and cash equivalents |
6,538 | (22,270) | ||||||
|
|
|
|
|||||
Net change in cash and cash equivalents |
91,621 | (3,420) | ||||||
Cash and cash equivalents at beginning of year |
630,193 | 633,613 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at end of year |
721,814 | 630,193 | ||||||
|
|
|
|
- 12 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
6. NOTE FOR GOING CONCERN ASSUMPTION
Not applicable.
7. SEGMENT INFORMATION
SEGMENT INFORMATION BY BUSINESS UNIT
Results for the fourth quarter | Millions of yen | |||||||||||||
|
Three months ended December 31, 2017 |
Three months ended December 31, 2016 |
Change(%) | |||||||||||
Office |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
492,594 | 484,656 | + | 1.6 | ||||||||||
Intersegment |
605 | 1,194 | - | 49.3 | ||||||||||
|
|
|
|
|
|
|
||||||||
Total |
493,199 | 485,850 | + | 1.5 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
465,909 | 437,225 | + | 6.6 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
27,290 | 48,625 | - | 43.9 | ||||||||||
|
|
|
|
|
|
|
||||||||
Imaging System |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
340,738 | 324,455 | + | 5.0 | ||||||||||
Intersegment |
182 | 287 | - | 36.6 | ||||||||||
|
|
|
|
|
|
|
||||||||
Total |
340,920 | 324,742 | + | 5.0 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
281,899 | 273,040 | + | 3.2 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
59,021 | 51,702 | + | 14.2 | ||||||||||
|
|
|
|
|
|
|
||||||||
Medical System |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
103,508 | - | - | |||||||||||
Intersegment |
174 | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Total |
103,682 | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
98,742 | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
4,940 | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Industry and Others |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
183,451 | 156,062 | + | 17.6 | ||||||||||
Intersegment |
21,833 | 19,572 | + | 11.6 | ||||||||||
|
|
|
|
|
|
|
||||||||
Total |
205,284 | 175,634 | + | 16.9 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
189,183 | 172,472 | + | 9.7 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
16,101 | 3,162 | + | 409.2 | ||||||||||
|
|
|
|
|
|
|
||||||||
Corporate and Eliminations |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
- | - | - | |||||||||||
Intersegment |
(22,794) | (21,053) | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Total |
(22,794) | (21,053) | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
5,522 | 2,268 | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
(28,316) | (23,321) | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Consolidated |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
1,120,291 | 965,173 | + | 16.1 | ||||||||||
Intersegment |
- | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Total |
1,120,291 | 965,173 | + | 16.1 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
1,041,255 | 885,005 | + | 17.7 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
79,036 | 80,168 | - | 1.4 | ||||||||||
|
|
|
|
|
|
|
*Canon newly established Medical System Business Unit effective at the beginning of the second quarter of 2017, and certain businesses included in Industry and Others Business Unit have been reclassified. Operating results for the three months ended December 31, 2016 were not restated since they were not material.
*Operating results pertaining to TMSC, a company acquired in December 2016, are included in Medical System for the fourth quarter of 2017. Amortization costs of identified intangible assets resulting from the purchase price allocation of TMSC are included in Corporate and Eliminations.
Reconciliation from Operating profit to Adjusted operating profit
Millions of yen | ||||||||||||||
Three months ended December 31, 2017 |
Three months ended December 31, 2016 |
|||||||||||||
Office |
||||||||||||||
Operating profit |
27,290 | 48,625 | ||||||||||||
Impairment losses on goodwill |
33,912 | - | ||||||||||||
|
|
|
|
|||||||||||
Adjusted operating profit |
61,202 | 48,625 | ||||||||||||
|
|
|
|
|||||||||||
Consolidated |
||||||||||||||
Operating profit |
79,036 | 80,168 | ||||||||||||
Impairment losses on goodwill |
33,912 | - | ||||||||||||
|
|
|
|
|||||||||||
Adjusted operating profit |
112,948 | 80,168 | ||||||||||||
|
|
|
|
- 13 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
Results for the fiscal year | Millions of yen | |||||||||||||
Year ended December 31, 2017 |
Year ended December 31, 2016 |
Change(%) | ||||||||||||
Office |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
1,863,688 | 1,804,862 | + | 3.3 | ||||||||||
Intersegment |
2,240 | 2,957 | - | 24.2 | ||||||||||
|
|
|
|
|
|
|
||||||||
Total |
1,865,928 | 1,807,819 | + | 3.2 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
1,685,280 | 1,638,333 | + | 2.9 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
180,648 | 169,486 | + | 6.6 | ||||||||||
|
|
|
|
|
|
|
||||||||
Total assets |
962,006 | 961,749 | + | 0.0 | ||||||||||
Depreciation and amortization |
74,377 | 78,319 | - | 5.0 | ||||||||||
Capital expenditures |
47,653 | 72,189 | - | 34.0 | ||||||||||
|
|
|
|
|
|
|
||||||||
Imaging System |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
1,135,584 | 1,094,291 | + | 3.8 | ||||||||||
Intersegment |
604 | 998 | - | 39.5 | ||||||||||
|
|
|
|
|
|
|
||||||||
Total |
1,136,188 | 1,095,289 | + | 3.7 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
960,275 | 950,876 | + | 1.0 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
175,913 | 144,413 | + | 21.8 | ||||||||||
|
|
|
|
|
|
|
||||||||
Total assets |
387,088 | 391,661 | - | 1.2 | ||||||||||
Depreciation and amortization |
41,695 | 47,386 | - | 12.0 | ||||||||||
Capital expenditures |
28,508 | 25,564 | + | 11.5 | ||||||||||
|
|
|
|
|
|
|
||||||||
Medical System |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
434,985 | - | - | |||||||||||
Intersegment |
1,202 | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Total |
436,187 | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
413,682 | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
22,505 | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Total assets |
238,824 | 204,755 | + | 16.6 | ||||||||||
Depreciation and amortization |
5,212 | - | - | |||||||||||
Capital expenditures |
8,963 | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Industry and Others | ||||||||||||||
Net sales: |
||||||||||||||
External customers |
645,758 | 502,334 | + | 28.6 | ||||||||||
Intersegment |
85,946 | 82,326 | + | 4.4 | ||||||||||
|
|
|
|
|
|
|
||||||||
Total |
731,704 | 584,660 | + | 25.2 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
674,916 | 577,212 | + | 16.9 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
56,788 | 7,448 | + | 662.5 | ||||||||||
|
|
|
|
|
|
|
||||||||
Total assets |
360,271 | 340,455 | + | 5.8 | ||||||||||
Depreciation and amortization |
37,705 | 41,053 | - | 8.2 | ||||||||||
Capital expenditures |
15,736 | 29,346 | - | 46.4 | ||||||||||
|
|
|
|
|
|
|
||||||||
Corporate and Eliminations |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
- | - | - | |||||||||||
Intersegment |
(89,992) | (86,281) | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Total |
(89,992) | (86,281) | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
14,383 | 6,200 | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
(104,375) | (92,481) | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Total assets |
3,250,102 | 3,239,909 | + | 0.3 | ||||||||||
Depreciation and amortization |
102,892 | 83,338 | + | 23.5 | ||||||||||
Capital expenditures |
80,529 | 81,280 | - | 0.9 | ||||||||||
|
|
|
|
|
|
|
||||||||
Consolidated |
||||||||||||||
Net sales: |
||||||||||||||
External customers |
4,080,015 | 3,401,487 | + | 19.9 | ||||||||||
Intersegment |
- | - | - | |||||||||||
|
|
|
|
|
|
|
||||||||
Total |
4,080,015 | 3,401,487 | + | 19.9 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating cost and expenses |
3,748,536 | 3,172,621 | + | 18.2 | ||||||||||
|
|
|
|
|
|
|
||||||||
Operating profit |
331,479 | 228,866 | + | 44.8 | ||||||||||
|
|
|
|
|
|
|
||||||||
Total assets |
5,198,291 | 5,138,529 | + | 1.2 | ||||||||||
Depreciation and amortization |
261,881 | 250,096 | + | 4.7 | ||||||||||
Capital expenditures |
181,389 | 208,379 | - | 13.0 | ||||||||||
|
|
|
|
|
|
|
*Canon newly established Medical System Business Unit effective at the beginning of the second quarter of 2017, and certain businesses included in Industry and Others Business Unit have been reclassified. Total assets as of December 31, 2016 have been restated to comply with this change. Operating results for the year ended December 31, 2016, however, were not restated since they were not material.
*Operating results pertaining to TMSC, a company acquired in December 2016, are included in Medical System for the year ended December 31, 2017. Amortization costs of identified intangible assets resulting from the purchase price allocation of TMSC are included in Corporate and Eliminations.
- 14 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
Reconciliation from Operating profit to Adjusted operating profit
Millions of yen | ||||||||||||
Year ended December 31, 2017 |
Year ended December 31, 2016 |
|||||||||||
Office |
||||||||||||
Operating profit |
180,648 | 169,486 | ||||||||||
Impairment losses on goodwill |
33,912 | - | ||||||||||
|
|
|
|
|||||||||
Adjusted operating profit |
214,560 | 169,486 | ||||||||||
|
|
|
|
|||||||||
Consolidated |
||||||||||||
Operating profit |
331,479 | 228,866 | ||||||||||
Impairment losses on goodwill |
33,912 | - | ||||||||||
|
|
|
|
|||||||||
Adjusted operating profit |
365,391 | 228,866 | ||||||||||
|
|
|
|
8. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES
Canons consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles.
Recently Issued Accounting Guidance
In January 2017, the Financial Accounting Standards Board issued an amendment which eliminates the second step from the impairment test of goodwill. This amendment requires the entity to recognize an impairment charge for the amount by which the carrying amount exceeds the fair value of reporting unit; however, the impairment charge is limited to the amount of goodwill allocated to that reporting unit. Canon early adopted this amended guidance from the impairment test performed after January 1, 2017.
9. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(1) NET INCOME ATTRIBUTABLE TO CANON INC. SHAREHOLDERS PER SHARE
Results for the fiscal year | Millions of yen | |||||||
Year ended December 31, 2017 |
Year ended December 31, 2016 |
|||||||
Net income attributable to Canon Inc. |
||||||||
-Basic |
241,923 | 150,650 | ||||||
-Diluted |
241,923 | 150,650 | ||||||
Number of shares | ||||||||
Average common shares outstanding |
||||||||
-Basic |
1,085,439,370 | 1,092,070,680 | ||||||
-Diluted |
1,085,439,370 | 1,092,070,680 | ||||||
Yen | ||||||||
Net income attributable to |
||||||||
Canon Inc. shareholders per share: |
||||||||
-Basic |
222.88 | 137.95 | ||||||
-Diluted |
222.88 | 137.95 |
(2) SUBSEQUENT EVENT
There | is no significant subsequent event. |
- 15 -
CANON INC. AND SUBSIDIARIES
CONSOLIDATED
Canon has decided to discontinue the disclosure of the below items in this report from this quarter. The information will be disclosed in such other reports as Form 20-F for the year ended December 31, 2017.
-Non-Consolidated Results
-Non-Consolidated Results in Operating Results and Financial Conditions
-Basic Policy Regarding Profit Distribution and Dividends for the Current Fiscal Year in Operating Results and Financial Conditions
-Group Position
-Management Policy
-Group Position in Basis of Presentation and Significant Accounting Policies
-Notes to Consolidated Financial Statements except for Net Income Attributable to Canon Inc. Shareholders per Share and Subsequent
Event
-Note for non-GAAP Financial Measures (Free cash flow)
-Non-Consolidated Financial Statements
In addition, Canon has decided to discontinue the distribution of its Supplementary Report within this report. The information will be available in Financial Results and Presentation Materials for fiscal year 2017 on Canons website.
- 16 -
NON-CONSOLIDATED
(Current Titles are Shown in the Parentheses)
Effective Date: March 29, 2018
Audit & Supervisory Board Members
(1) Candidates for new Audit & Supervisory Board Member to be appointed
Masaaki Nakamura |
(Managing Executive Officer, Group Executive of Public Affairs Headquarters) | |
Koichi Kashimoto |
(Senior General Manager of The Dai-ichi Life Insurance Company, Limited. / Chief of Dai-ichi Life Holdings, Inc.) |
(2) Audit & Supervisory Board Members to be retired
Makoto Araki |
Kuniyoshi Kitamura |
- 17 -
NON-CONSOLIDATED
(Current Titles are Shown in the Parentheses)
Executive Officers
(1) New Executive Officers to be appointed
Effective date: April 1, 2018
Katsuyoshi Soma |
(President of Fukushima Canon Inc.) | |
Masaki Omori |
(Senior General Manager of Production Engineering Research Laboratory) |
(2) Executive Officers to be retired
Effective date: March 31, 2018
Rokus van Iperen |
(Senior Managing Executive Officer, President & CEO of Canon Europe Ltd. & Canon Europa N.V.) | |
Yasuhiro Tani |
(Senior Managing Executive Officer, Group Executive of Digital System Technology Development Headquarters) | |
Hiroyuki Suematsu |
(Managing Executive Officer, Group Executive of Corporate Planning Development Headquarters) |
Effective date: March 29, 2018
Masaaki Nakamura |
(Managing Executive Officer, Group Executive of Public Affairs Headquarters) |
- 18 -